NKGen Biotech, Inc. Common Stock (NKGN) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 652K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | -100% | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 326K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15K | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | 50% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 326K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15K | 3K | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | 50% | - | - | - | - | - | - | - | - | 100% | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | 100% | -100% | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 4.67M | 5.43M | 6.79M | 7.46M | 7.62M | 9.43M | 6.9M | 6.61M | 6.8M | 6.25M | 6M | 968.96K | 731.91K | 1.41M | 804.04K | 262.39K |
| OpEx % of Revenue | - | 832.21% | - | - | - | - | - | - | - | - | 199833.33% | - | - | - | - | - |
| Selling, General & Admin | 2.81M | 3.58M | 4.01M | 4.37M | 4.38M | 5.34M | 2.97M | 2.56M | 3.2M | 2.16M | 1.87M | 919.64K | 683.14K | 1.35M | 737.22K | 229.54K |
| SG&A % of Revenue | - | 548.31% | - | - | - | - | - | - | - | - | 62466.67% | - | - | - | - | - |
| Research & Development | 1.86M | 1.85M | 2.78M | 3.09M | 3.24M | 4.09M | 3.93M | 4.05M | 3.6M | 4.09M | 4.12M | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | 283.9% | - | - | - | - | - | - | - | - | 137366.67% | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.32K | 48.77K | 51.51K | 66.82K | 32.85K |
| Operating Income | -4.67M | -5.1M | -6.79M | -7.46M | -7.62M | -9.43M | -6.9M | -6.61M | -6.8M | -6.26M | -5.99M | -968.96K | -731.91K | -1.41M | -804.04K | -262.39K |
| Operating Margin % | - | -782.21% | - | - | - | - | - | - | - | - | -199733.33% | - | - | - | - | - |
| Operating Income Growth % | 38.77% | 45.93% | 1.67% | -12.8% | -12.11% | -50.67% | -15.2% | -582.28% | -828.8% | -345.21% | -645.24% | -269.28% | - | - | - | - |
| EBITDA | -4.29M | -6.08M | -6.46M | -7.13M | -7.29M | -9.13M | -6.6M | -6.31M | -6.49M | -5.51M | -6.06M | -968.96K | -731.91K | -1.41M | -804.04K | -262.39K |
| EBITDA Margin % | - | -933.13% | - | - | - | - | - | - | - | - | -201900% | - | - | - | - | - |
| EBITDA Growth % | 41.23% | 33.38% | 2.23% | -12.98% | -12.33% | -65.61% | -9.01% | -551.42% | -787.27% | -292.15% | -653.32% | -269.28% | - | - | - | - |
| D&A (Non-Cash Add-back) | 379K | -984K | 332K | 326K | 326K | 300K | 300K | 299K | 304K | 746K | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 15.86M | 12.68M | 7.07M | -15.44M | -4.31M | -33.16M | -32.97M | -7.79M | -8.29M | -6.33M | -6.06M | -968.96K | -731.91K | -1.41M | -804.04K | -262.39K |
| Net Interest Income | -509K | 2.19M | -472K | -647K | -1.07M | -438K | -211K | -62K | -34K | -616K | -636K | 124.76K | 44.03K | 19.73K | 21.28K | 136 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 124.76K | 44.03K | 19.73K | 21.28K | 136 |
| Interest Expense | 509K | 4.91M | 472K | 647K | 1.07M | 438K | 211K | 62K | 34K | 616K | 636K | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 20.02M | -24.26M | 13.39M | -8.63M | 2.24M | -24.17M | -26.27M | -1.24M | -1.52M | -681K | -701K | 5.63M | 2.74M | 66.95K | 5.5M | -4.05M |
| Pretax Income | 15.35M | -29.36M | 6.6M | -16.09M | -5.38M | -33.6M | -33.18M | -7.85M | -8.32M | -6.94M | -6.69M | 4.67M | 2M | -1.34M | 4.69M | -4.31M |
| Pretax Margin % | - | -4503.22% | - | - | - | - | - | - | - | - | -223100% | - | - | - | - | - |
| Income Tax | 0 | 53K | 0 | 0 | 0 | 7K | 0 | 0 | 0 | 7K | 0 | -15.4K | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -0.18% | 0% | 0% | 0% | -0.02% | 0% | 0% | 0% | -0.1% | 0% | -0.33% | 0% | 0% | 0% | 0% |
| Net Income | 15.35M | -29.41M | 6.6M | -16.09M | -5.38M | -33.61M | -33.18M | -7.85M | -8.32M | -6.95M | -6.69M | 4.68M | 2M | -1.34M | 4.69M | -4.31M |
| Net Margin % | - | -4511.35% | - | - | - | - | - | - | - | - | -223100% | - | - | - | - | - |
| Net Income Growth % | 385.21% | 12.47% | 119.89% | -104.97% | 35.33% | -383.68% | -395.7% | -267.69% | -515.4% | -418.84% | -242.58% | 208.6% | - | - | - | - |
| Net Income (Continuing) | 15.35M | -29.41M | 6.6M | -16.09M | -5.38M | -33.61M | -33.18M | -7.85M | -8.32M | -6.95M | -6.69M | 4.68M | 2M | -1.34M | 4.69M | -4.31M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.04 | -0.77 | 0.15 | -0.67 | -0.25 | -1.54 | -2.48 | -0.11 | 0.02 | -0.14 | 0.04 | 0.22 | 0.09 | -0.06 | 0.22 | -0.20 |
| EPS Growth % | 84% | 50% | 106.05% | -509.09% | -1512.43% | -1000% | -6090.34% | -150% | -81.05% | -124.36% | -81.18% | 210% | - | - | - | - |
| EPS (Basic) | 0.33 | -0.84 | 0.22 | -0.67 | -0.25 | -1.54 | -2.48 | -0.11 | 0.02 | -0.14 | 0.04 | 0.22 | 0.09 | -0.06 | 0.22 | -0.20 |
| Diluted Shares Outstanding | 28.83M | 28.83M | 24.17M | 24.17M | 21.94M | 21.89M | 13.4M | 16.83M | 21.45M | 21.45M | 21.45M | 21.45M | 21.45M | 21.45M | 21.45M | 21.45M |
| Basic Shares Outstanding | 28.83M | 28.83M | 29.13M | 24.17M | 21.94M | 21.89M | 13.4M | 16.83M | 21.45M | 21.45M | 21.45M | 21.45M | 21.45M | 21.45M | 21.45M | 21.45M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |